Rampart Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-14,188
Closed -$855K 49
2020
Q3
$855K Sell
14,188
-27,964
-66% -$1.68M 0.54% 58
2020
Q2
$2.48M Buy
42,152
+23,735
+129% +$1.42M 0.42% 66
2020
Q1
$1.03M Sell
18,417
-9,340
-34% -$571K 0.49% 48
2019
Q4
$1.78M Buy
27,757
+9,289
+50% +$532K 0.22% 136
2019
Q3
$937K Sell
18,468
-8,721
-32% -$410K 0.12% 224
2019
Q2
$1.23M Sell
27,189
-1,514
-5% -$70.5K 0.15% 197
2019
Q1
$1.37M Buy
28,703
+11,177
+64% +$557K 0.16% 193
2018
Q4
$911K Sell
17,526
-10,654
-38% -$572K 0.25% 103
2018
Q3
$1.13M Sell
28,180
-2,877
-9% -$171K 0.49% 48
2018
Q2
$1.72M Sell
31,057
-12,788
-29% -$691K 0.17% 168
2018
Q1
$2.77M Buy
43,845
+23,732
+118% +$1.53M 0.27% 115
2017
Q4
$1.23M Sell
20,113
-2,431
-11% -$152K 0.47% 48
2017
Q3
$1.44M Buy
22,544
+1,192
+6% +$69.6K 0.49% 46
2017
Q2
$1.19M Buy
21,352
+16,635
+353% +$905K 0.43% 48
2017
Q1
$257K Buy
+4,717
New +$259K 0.09% 54

Other funds holding BMY

Rampart Investment Management's BMY Position: Q4 2020 in Review

Rampart Investment Management sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 14,188 shares — an estimated $855K sold.

Rampart Investment Management first reported a position in BMY in Q1 2017 and held it in 15 quarters. The position peaked at $2.77M in Q1 2018. 2,360 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Rampart Investment Management reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 14,188 Bristol-Myers Squibb shares in Q4 2020, an estimated $855K.
  • Rampart Investment Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 15 quarters.
  • Rampart Investment Management's Bristol-Myers Squibb position peaked at $2.77M in Q1 2018.
  • 2,360 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.